Home › Companies › GoodRx Holdings, Inc. › 2025-2026

GoodRx Holdings, Inc. 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and GoodRx Holdings, Inc.’s Form 8-K, filed June 18, 2026 (Item 5.07 on EDGAR). Page generated October 14, 2026.

  • 5Ballot items
  • 132Asset managers
  • 493Fund votes
  • June 16, 2026Meeting date

Results at a glance

Meeting of June 16, 2026: 5 items on GoodRx Holdings, Inc.’s Form 8-K, filed June 18, 2026: 5 without a stated outcome.

Material dissent

None.

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore GoodRx Holdings, Inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by GoodRx Holdings, Inc.

These tallies are GoodRx Holdings, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 18, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

GoodRx Holdings, Inc. — official shareholder meeting results, meeting held June 16, 2026
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Wendy Barnes 2,379,952,868---- 10,078,86039,543,093 99.5%Not verified—
Elect Director: Ronald E. Bruehlman 2,380,863,641---- 9,168,08739,543,093 99.6%Not verified—
Elect Director: Gregory Mondre 2,382,474,121---- 7,557,60739,543,093 99.6%Not verified—
2. Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 2,429,055,999335,716183,106 --0 99.9%Not verified—
3. Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers 2,363,913,37023,702,5202,415,838 --39,543,093 99.0%Not verified—

Source: GoodRx Holdings, Inc., Form 8-K, filed with the SEC on June 18, 2026 — read the filing on EDGAR.

How asset managers voted at the GoodRx Holdings, Inc. 2025-2026 meeting

Each item below shows how the 132 asset managers that disclosed a GoodRx Holdings, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. Elect Director: Gregory Mondre

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

99.6% Majority: yes · of votes cast

FOR 99.6%
FOR: 2,382,474,121WITHHELD: 7,557,607
Details: description as filed, official tally, votes by 25 asset managers

Description as filed by funds: Election of Directors: Gregory Mondre

GoodRx Holdings, Inc.’s own tally for this item (“Elect Director: Gregory Mondre”): 2,382,474,121 for, 7,557,607 withheld, per its Form 8-K filed June 18, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.6% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 25 asset managers below reported 9,799,803 for, 697,952 withheld, 43,143 abstained.

FOR
FOR: 9,799,803ABSTAIN: 43,143WITHHOLD: 697,952
Largest asset managers voting on “Election of Directors: Gregory Mondre” at GoodRx Holdings, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard7,556,3260 378,748For
Pacer Funds Trust742,3620 00For
Charles Schwab562,0750 00For
SEI396,3000 00For
Invesco288,6580 00For
Northern Trust00 0256,892Withhold
WisdomTree00 0172,695Withhold
Dimensional00 0143,668Withhold
Fidelity102,0940 041,272Mixed
Harbor ETF Trust70,4030 00For
Legg Mason38,1140 00For
BlackRock00 37,8350Abstain
American Century00 029,169Withhold
Russell Investments27,4010 00For
State Street250 023,095Withhold
Goldman Sachs16,0450 00For
Prudential/PGIM00 012,470Withhold
Lincoln Financial00 08,959Withhold
Allianz00 3,0970Abstain
John Hancock00 2,0900Abstain
Advisors' Inner Circle Fund III00 0501Withhold
Blackstone Alternative Investment Funds00 0300Withhold
Victory Capital00 0103Withhold
Jackson National00 840Abstain
E Trade Trust00 080Withhold

2. Elect Director: Ronald E. Bruehlman

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

99.6% Majority: yes · of votes cast

FOR 99.6%
FOR: 2,380,863,641WITHHELD: 9,168,087
Details: description as filed, official tally, votes by 25 asset managers

Description as filed by funds: Election of Directors: Ronald E. Bruehlman

GoodRx Holdings, Inc.’s own tally for this item (“Elect Director: Ronald E. Bruehlman”): 2,380,863,641 for, 9,168,087 withheld, per its Form 8-K filed June 18, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.6% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 25 asset managers below reported 10,168,136 for, 367,465 withheld, 5,297 abstained.

FOR
FOR: 10,168,136ABSTAIN: 5,297WITHHOLD: 367,465
Largest asset managers voting on “Election of Directors: Ronald E. Bruehlman” at GoodRx Holdings, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard7,565,0850 260For
Pacer Funds Trust742,3620 00For
Charles Schwab562,0750 00For
SEI396,3000 00For
Invesco288,6580 00For
Northern Trust256,8920 00For
WisdomTree00 0172,695Withhold
Dimensional00 0143,668Withhold
Fidelity143,3660 00For
Harbor ETF Trust70,4030 00For
Legg Mason38,1140 00For
BlackRock37,8350 00For
American Century00 029,169Withhold
Russell Investments27,4010 00For
State Street23,0990 021For
Goldman Sachs16,0450 00For
Prudential/PGIM00 012,470Withhold
Lincoln Financial00 08,959Withhold
Allianz00 3,0970Abstain
John Hancock00 2,0900Abstain
Advisors' Inner Circle Fund III5010 00For
Blackstone Alternative Investment Funds00 0300Withhold
Victory Capital00 0103Withhold
Jackson National00 840Abstain
E Trade Trust00 080Withhold

3. Elect Director: Wendy Barnes

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

99.5% Majority: yes · of votes cast

FOR 99.5%
FOR: 2,379,952,868WITHHELD: 10,078,860
Details: description as filed, official tally, votes by 25 asset managers

Description as filed by funds: Election of Directors: Wendy Barnes

GoodRx Holdings, Inc.’s own tally for this item (“Elect Director: Wendy Barnes”): 2,379,952,868 for, 10,078,860 withheld, per its Form 8-K filed June 18, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.5% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 25 asset managers below reported 9,879,477 for, 656,123 withheld, 5,298 abstained.

FOR
FOR: 9,879,477ABSTAIN: 5,298WITHHOLD: 656,123
Largest asset managers voting on “Election of Directors: Wendy Barnes” at GoodRx Holdings, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard7,565,0840 270For
Pacer Funds Trust742,3620 00For
Charles Schwab562,0750 00For
SEI396,3000 00For
Invesco00 0288,658Withhold
Northern Trust256,8920 00For
WisdomTree00 0172,695Withhold
Dimensional00 0143,668Withhold
Fidelity143,3660 00For
Harbor ETF Trust70,4030 00For
Legg Mason38,1140 00For
BlackRock37,8350 00For
American Century00 029,169Withhold
Russell Investments27,4010 00For
State Street23,0990 021For
Goldman Sachs16,0450 00For
Prudential/PGIM00 012,470Withhold
Lincoln Financial00 08,959Withhold
Allianz00 3,0970Abstain
John Hancock00 2,0900Abstain
Advisors' Inner Circle Fund III5010 00For
Blackstone Alternative Investment Funds00 0300Withhold
Victory Capital00 0103Withhold
Jackson National00 840Abstain
E Trade Trust00 080Withhold

4. 3. Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers

Outcome not verifiedFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Not verified

Combines 7 wordings of this item as funds reported it.

99.0% Majority: yes · of votes cast

FOR 99.0%
FOR: 2,363,913,370AGAINST: 23,702,520
Details: description as filed, official tally, votes by 132 asset managers

Description as filed by funds: APPROVAL, ON AN ADVISORY (NON-BINDING) BASIS, OF THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.

GoodRx Holdings, Inc.’s own tally for this item (“3. Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers”): 2,363,913,370 for, 23,702,520 against, per its Form 8-K filed June 18, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.0% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 25 asset managers voting on “APPROVAL, ON AN ADVISORY (NON-BINDING) BASIS, OF THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.” at GoodRx Holdings, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard4,196,5503,368,548 130Mixed
Pacer Funds Trust0742,362 00Against
Charles Schwab0562,075 00Against
SEI0396,300 00Against
Invesco0288,658 00Against
Northern Trust0256,892 00Against
WisdomTree0172,695 00Against
Dimensional0143,668 00Against
Fidelity0143,366 00Against
Harbor ETF Trust70,4030 00For
Legg Mason00 38,1140Abstain
BlackRock037,835 00Against
American Century29,1690 00For
Russell Investments027,401 00Against
State Street23,07743 00For
Goldman Sachs16,0450 00For
Prudential/PGIM012,470 00Against
Lincoln Financial08,959 00Against
Allianz03,097 00Against
John Hancock02,090 00Against
Advisors' Inner Circle Fund III0501 00Against
Blackstone Alternative Investment Funds0300 00Against
Victory Capital0103 00Against
Jackson National084 00Against
E Trade Trust080 00Against

Fund voting reports, all 25 managers: 4,335,244 for, 6,167,527 against, 38,127 abstained.

Institutional-manager reports: 120 asset managers voting on “APPROVAL, ON AN ADVISORY (NON-BINDING) BASIS, OF THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.” at GoodRx Holdings, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Silver Lake Group, L.L.C.129,527,6080 00For
Francisco Partners Management, LP60,078,1840 00For
Petrus Trust Company, LTA3,098,5590 00For
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.00 2,105,5020Abstain
LSV ASSET MANAGEMENT02,088,134 00Against
Technology Crossover Management X, Ltd.1,653,5660 00For
AMERIPRISE FINANCIAL INC01,439,024 00Against
BlackRock16,1481,224,032 00Against
AQR0952,893 00Against
Invesco0792,850 00Against
STIFEL NICOLAUS & CO INC \MO\0792,486 00Against
Vanguard665,94523,762 00For
Charles Schwab0563,299 00Against
Goldman Sachs468,6430 00For
SEI0397,064 00Against
Universal-Investment-Gesellschaft mbH0379,634 00Against
Victory Capital0350,717 00Against
MACKENZIE FINANCIAL CORP0348,989 00Against
MOORE CAPITAL MANAGEMENT, LP0300,838 00Against
UI BVK Kapitalverwaltungsgesellschaft mbH0286,300 00Against
Janney Montgomery Scott LLC0203,088 00Against
Evercore Wealth Management, LLC0184,834 00Against
Northern Trust0184,096 00Against
WELLS FARGO CLEARING SERVICES, LLC162,3010 00For
Renaissance0143,552 00Against

Institutional-manager reports, all 120 managers: 196,026,867 for, 11,834,602 against, 2,143,616 abstained. Showing the 25 largest; see all in the interactive database.

5. 2. Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the…

Outcome not verifiedAUDIT-RELATEDReported outcome: Not verified

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 2,429,055,999AGAINST: 335,716
Details: description as filed, official tally, votes by 25 asset managers

Description as filed by funds: RATIFICATION OF THE APPOINTMENT OF KPMG LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2026.

GoodRx Holdings, Inc.’s own tally for this item (“2. Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026”): 2,429,055,999 for, 335,716 against, per its Form 8-K filed June 18, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 25 asset managers below reported 10,540,897 for.

FOR
FOR: 10,540,897
Largest asset managers voting on “RATIFICATION OF THE APPOINTMENT OF KPMG LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR” at GoodRx Holdings, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard7,565,1100 00For
Pacer Funds Trust742,3620 00For
Charles Schwab562,0750 00For
SEI396,3000 00For
Invesco288,6580 00For
Northern Trust256,8920 00For
WisdomTree172,6950 00For
Dimensional143,6680 00For
Fidelity143,3660 00For
Harbor ETF Trust70,4030 00For
Legg Mason38,1140 00For
BlackRock37,8350 00For
American Century29,1690 00For
Russell Investments27,4010 00For
State Street23,1200 00For
Goldman Sachs16,0450 00For
Prudential/PGIM12,4700 00For
Lincoln Financial8,9590 00For
Allianz3,0970 00For
John Hancock2,0900 00For
Advisors' Inner Circle Fund III5010 00For
Blackstone Alternative Investment Funds3000 00For
Victory Capital1030 00For
Jackson National840 00For
E Trade Trust800 00For

Largest GoodRx Holdings, Inc. shareholders voting in 2025-2026

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 340,531,000 shares outstanding at the time of that meeting.

Fund voting reports: top GoodRx Holdings, Inc. shareholders by shares voted on “APPROVAL, ON AN ADVISORY (NON-BINDING) BASIS, OF THE COMPENSATION OF THE COMPANY'S NAMED…”, 2025-2026
#Asset manager % of shares outstanding
1Vanguard 2.22%
2Pacer Funds Trust 0.22%
3Charles Schwab 0.17%
4SEI 0.12%
5Invesco 0.08%
6Northern Trust 0.08%
7WisdomTree 0.05%
8Dimensional 0.04%
9Fidelity 0.04%
10Harbor ETF Trust 0.02%
Institutional-manager reports: top GoodRx Holdings, Inc. shareholders by shares voted on “APPROVAL, ON AN ADVISORY (NON-BINDING) BASIS, OF THE COMPENSATION OF THE COMPANY'S NAMED…”, 2025-2026
#Asset manager % of shares outstanding
1Silver Lake Group, L.L.C. 38.04%
2Francisco Partners Management, LP 17.64%
3Petrus Trust Company, LTA 0.91%
4PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 0.62%
5LSV ASSET MANAGEMENT 0.61%
6Technology Crossover Management X, Ltd. 0.49%
7AMERIPRISE FINANCIAL INC 0.42%
8BlackRock 0.36%
9AQR 0.28%
10Invesco 0.23%

Reported GoodRx Holdings, Inc. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

GoodRx Holdings, Inc. holdings and ownership disclosed for the 2025-2026 proxy season
Holder % outstanding Disclosure
Francisco Partners GP IV, L.P. 15.44% 13D
Vanguard Group 2.81% 13F
Renaissance Technologies 0.96% 13F
Dimensional Fund Advisors 0.72% 13F
BlackRock 0.55% 13F
AQR Capital 0.53% 13F
Morgan Stanley 0.33% 13F
Geode Capital 0.32% 13F
Goldman Sachs 0.31% 13F
State Street 0.30% 13F

Percentages above are of 340,531,000 shares outstanding, as reported by GoodRx Holdings, Inc. on its Form 10-Q dated March 31, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from GoodRx Holdings, Inc.’s 10-Q dated March 31, 2026. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.

At GoodRx Holdings, Inc.'s shareholder meeting held June 16, 2026, in the 2025-2026 proxy season, 132 asset managers reported how they voted on 5 ballot items in their SEC Form N-PX filings, covering 493 separate fund positions. On the most widely held item on that ballot — APPROVAL, ON AN ADVISORY (NON-BINDING) BASIS, OF THE COMPENSATION OF THE COMPANY'S NAMED… — FOR was 99.0% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: GoodRx Holdings, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 18, 2026.

GoodRx Holdings, Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).

Download data (CSV): ballot items · votes by manager · column guide.